Literature DB >> 12793980

Alterations in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats.

Takayuki Matsumoto1, Tsuneo Kobayashi, Katsuo Kamata.   

Abstract

In isolated superior mesenteric artery rings from age-matched control rats and streptozotocin (STZ)-induced diabetic rats, we investigated the role of cAMP in endothelium-derived hyperpolarizing factor (EDHF)-type relaxation. The ACh-induced EDHF-type relaxation was significantly weaker in STZ-induced diabetic rats than in control rats, and in both groups of rats it was attenuated by 18alpha-glycyrrhetinic acid (18alpha-GA), an inhibitor of gap junctions, and enhanced by IBMX, a cAMP-phosphodiesterase (PDE) inhibitor. These enhanced EDHF-type responses were very similar in magnitude between diabetic and age-matched control rats. The EDHF-type relaxation was enhanced by cilostamide, a PDE3-selective inhibitor, but not by Ro 20-1724, a PDE4-selective inhibitor. The expression levels of the mRNAs and proteins for two cAMP PDEs (PDE3A, PDE3B) were significantly increased in STZ-induced diabetic rats, but those for PDE4D were not. We conclude that the impairment of EDHF-type relaxations in STZ-induced diabetic rats may be attributed to a reduction in the action of cAMP via increased PDE activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12793980     DOI: 10.1152/ajpheart.00954.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  23 in total

Review 1.  Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses.

Authors:  Cor de Wit; Tudor M Griffith
Journal:  Pflugers Arch       Date:  2010-04-09       Impact factor: 3.657

2.  Endothelium-derived hyperpolarizing factor and diabetes.

Authors:  Xue Gao; Luis A Martinez-Lemus; Cuihua Zhang
Journal:  World J Cardiol       Date:  2011-01-26

3.  Olprinone attenuates the development of ischemia/reperfusion injury of the gut.

Authors:  Concetta Crisafulli; Emanuela Mazzon; Maria Galuppo; Irene Paterniti; Rocco Caminiti; Salvatore Cuzzocrea
Journal:  Intensive Care Med       Date:  2010-03-27       Impact factor: 17.440

4.  Enhancement of mesenteric artery contraction to 5-HT depends on Rho kinase and Src kinase pathways in the ob/ob mouse model of type 2 diabetes.

Authors:  Takayuki Matsumoto; Tsuneo Kobayashi; Keiko Ishida; Kumiko Taguchi; Katsuo Kamata
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

5.  Enhanced endothelium derived hyperpolarising factor activity in resistance arteries from normal pressure glaucoma patients: implications for vascular function in the eye.

Authors:  C Cleary; C H Buckley; E Henry; P McLoughlin; C O'Brien; P W F Hadoke
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

6.  Mechanisms underlying lysophosphatidylcholine-induced potentiation of vascular contractions in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat aorta.

Authors:  T Matsumoto; T Kobayashi; K Kamata
Journal:  Br J Pharmacol       Date:  2006-10-09       Impact factor: 8.739

Review 7.  Endothelial control of vasodilation: integration of myoendothelial microdomain signalling and modulation by epoxyeicosatrienoic acids.

Authors:  David C Ellinsworth; Scott Earley; Timothy V Murphy; Shaun L Sandow
Journal:  Pflugers Arch       Date:  2013-06-08       Impact factor: 3.657

8.  Impaired EDHF-mediated vasodilatation in adult offspring of rats exposed to a fat-rich diet in pregnancy.

Authors:  P D Taylor; I Y Khan; M A Hanson; L Poston
Journal:  J Physiol       Date:  2004-06-11       Impact factor: 5.182

9.  Enhanced inhibition of the EDHF phenomenon by a phenyl methoxyalaninyl phosphoramidate derivative of dideoxyadenosine.

Authors:  Tudor M Griffith; Andrew T Chaytor; David H Edwards; Felice Daverio; Christopher McGuigan
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

10.  Differential effects of glucose on agonist-induced relaxations in human mesenteric and subcutaneous arteries.

Authors:  A MacKenzie; E J Cooper; F J Dowell
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.